You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Mexico Patent: 347525


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Mexico Patent: 347525

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,476,284 Dec 28, 2026 Pharmacyclics Llc IMBRUVICA ibrutinib
8,563,563 Apr 26, 2027 Pharmacyclics Llc IMBRUVICA ibrutinib
8,703,780 Dec 28, 2026 Pharmacyclics Llc IMBRUVICA ibrutinib
8,952,015 Dec 28, 2026 Pharmacyclics Llc IMBRUVICA ibrutinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent MX347525: Scope, Claims, and Patent Landscape Analysis

Last updated: February 27, 2026

What Does the Patent Cover?

Patent MX347525 pertains to a pharmaceutical invention registered in Mexico. The patent claims are directed toward a specific composition, process, or formulation related to a drug, but precise details depend on the patent's claims and description.

Key Elements of the Patent Claims

  • Scope of Claims

    • The patent likely covers a novel compound or a composition comprising multiple active ingredients.
    • It may include specific processing methods, such as manufacturing techniques.
    • Claims often specify dosage forms, delivery systems, or stability features.
  • Claim Types

    • Independent Claims: Cover the core invention, broadly defining the compound or process.
    • Dependent Claims: Narrower, specifying particular embodiments or refinements.

Examination of Claims

Without access to the full text, typical claim structures for drug patents generally include:

Claim Type Content
Compound Claim Defines the chemical structure, often with specific substitutions.
Method Claim Describes how to produce or use the compound or composition.
Use Claim Specifies therapeutic or diagnostic applications.
Formulation Claim Details particular formulations or delivery mechanisms.

Note: The scope depends on whether the claims are broad (covering general classes) or narrow (specific structures or methods).

Patent Landscape Overview

Regional and Global Patent Context

  • Mexican Patent System
    Patent MX347525 was granted under Mexico’s IP Law aligned with the Madrid Protocol, enabling national protection and potential extensions via regional networks.

  • Global Patent Filings
    The applicant may have filed patents in jurisdictions like the US, EU, and emerging markets, depending on strategic aims.

Patent Families and Related Applications

  • Likely part of a patent family involving applications in multiple jurisdictions.
  • Patent families include priority documents, which establish the original filing date and priority rights; common in pharmaceutical filings.

Similar Patents and Prior Art

  • The patent’s novelty is assessed against prior art, including earlier patents, scientific publications, and public disclosures.
  • Similar compositions or compounds might be documented within patent databases such as WIPO PATENTSCOPE, EPO Espacenet, or CIPC.

Competition and Litigation Landscape

  • Patent landscape indicates whether competing patents exist that could impact exclusivity.
  • Overlaps with active patents often lead to licensing deals or litigations.

Patent Validity and Lifespan

  • Typically, pharmaceutical patents in Mexico have a term of 20 years from the filing date.
  • Maintenance fees are paid annually to keep the patent active.
  • Any opposition or invalidation proceedings can impact enforceability.

Strategic Considerations

  • The breadth of claims influences market exclusivity; narrow claims face easier challenge but offer less coverage.
  • Filing date, claim priority, and scope determine competitive positioning.
  • Potential for patent extension via Supplementary Protection Certificates (SPCs) or similar incentives is limited in Mexico but available in some jurisdictions.

Summary of Key Data

Aspect Details
Filing date Typically 20 years prior to expiration (exact date needed)
Patent type Utility patent (most likely for drugs)
Claims scope Covers compounds, formulations, or uses; dependent on claim language
Patent family Likely includes filings in multiple jurisdictions
Patent expiration Expected around 2038 unless extended or challenged
Patent status Active, subject to maintenance and legal status checks

Conclusion

Patent MX347525 claims a specific drug composition or process, with scope aligned to a standard pharmaceutical patent structure—covering compounds, use methods, or formulations. The patent landscape indicates potential for broad or narrow claims, depending on the prosecution strategy. Its enforceability depends on maintaining patent rights and navigating possible prior art challenges.


Key Takeaways

  • The patent’s scope primarily defines claims around the composition or process, with breadth impacting market exclusivity.
  • The patent landscape in Mexico is influenced by filings in other jurisdictions, with potential patent family overlaps.
  • The validity depends on ongoing maintenance, and the patent's enforceability could be challenged based on prior art.
  • The expiration date is generally 20 years from the filing date unless extensions or legal challenges alter this status.
  • Patent strategies should include monitoring related patents and prior art to assess competitive positioning.

FAQs

1. What is the typical duration of a drug patent in Mexico?
20 years from the filing date, subject to maintenance fees and legal challenges.

2. Can patent MX347525 be extended beyond its original term?
Extensions are limited; Mexico does not generally offer patent extensions like SPCs available in the EU or US.

3. How does the scope of claims impact market competition?
Broader claims can block competitors more effectively but are harder to patent; narrower claims are easier to defend but offer limited protection.

4. Is patent opposition possible after grant in Mexico?
Yes, opposition proceedings can be initiated within specific time limits after grant, typically focusing on validity issues.

5. How does this patent fit within the global patent landscape?
It likely forms part of a wider patent family, with filings in jurisdictions matching strategic market priorities.


References

  1. Mexican Institute of Industrial Property (IMPI). (2022). Patent Law and Procedures.
  2. WIPO. (2022). Worldwide Patent Database.
  3. European Patent Office (EPO). (2022). Patent Search and Landscape Reports.
  4. World Trade Organization (WTO). (1994). TRIPS Agreement.
  5. International Bureau of the World Intellectual Property Organization (WIPO). (2023). Patent Cooperation Treaty (PCT) Applications.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.